This is a multi-center, randomized, double-blind, placebo-controlled, proof of concept study to assess the safety and tolerability of ANB020 in adult patients with peanut allergy.
The purpose of this study is to determine ANB020 safety, tolerability and activity in adult patients with peanut allergy.